0000874716-24-000015.txt : 20240209
0000874716-24-000015.hdr.sgml : 20240209
20240209170155
ACCESSION NUMBER: 0000874716-24-000015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240207
FILED AS OF DATE: 20240209
DATE AS OF CHANGE: 20240209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCKEON BRIAN P
CENTRAL INDEX KEY: 0001219445
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 24615950
MAIL ADDRESS:
STREET 1: IDEXX LABORATORIES
STREET 2: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
wk-form4_1707516080.xml
FORM 4
X0508
4
2024-02-07
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001219445
MCKEON BRIAN P
ONE IDEXX DRIVE
WESTBROOK
ME
04092
0
1
0
0
EVP, CFO and Treasurer
0
Common Stock
2024-02-07
4
M
0
23326
141.60
A
53043.5926
D
Common Stock
2024-02-07
4
S
0
615
563.8158
D
52428.5926
D
Common Stock
2024-02-07
4
S
0
1581
564.976
D
50847.5926
D
Common Stock
2024-02-07
4
S
0
701
566.533
D
50146.5926
D
Common Stock
2024-02-07
4
S
0
1564
567.3487
D
48582.5926
D
Common Stock
2024-02-07
4
S
0
1469
568.8449
D
47113.5926
D
Common Stock
2024-02-07
4
S
0
3912
569.9132
D
43201.5926
D
Common Stock
2024-02-07
4
S
0
5675
570.9697
D
37526.5926
D
Common Stock
2024-02-07
4
S
0
7128
571.8381
D
30398.5926
D
Common Stock
2024-02-07
4
S
0
681
572.8041
D
29717.5926
D
Common Stock
18050
I
by Estony McKeon Family, LLC
Non-Qualified Stock Option (right-to-buy)
141.60
2024-02-07
4
M
0
23326
D
2027-02-13
Common Stock
23326
0
D
Includes a total of 25.247 shares purchased under the Issuer Employee Stock Purchase Plan on September 29, 2023 and December 29, 2023.
Represents the weighted average price of the shares sold ranging from a low of $563.48 to a high of $564.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $564.63 to a high of $565.50 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $565.89 to a high of $566.84 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $566.92 to a high of $567.86 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $568.33 to a high of $569.28 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $569.34 to a high of $570.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $570.345 to a high of $571.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $571.36 to a high of $572.33 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $572.42 to a high of $573.09 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Grant of option to buy shares of Issuer common stock that vested in five annual installments beginning February 14, 2018.
Not applicable.
/s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon
2024-02-09